<?xml version="1.0" encoding="UTF-8"?>
<ref id="B37-marinedrugs-17-00567">
 <label>37.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Xue</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Hoorelbeke</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Kagiampakis</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Demeler</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Balzarini</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Liwang</surname>
    <given-names>P.J.</given-names>
   </name>
  </person-group>
  <article-title>The griffithsin dimer is required for high-potency inhibition of HIV-1: Evidence for manipulation of the structure of gp120 as part of the griffithsin dimer mechanism</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2013</year>
  <volume>57</volume>
  <fpage>3976</fpage>
  <lpage>3989</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.00332-13</pub-id>
  <pub-id pub-id-type="pmid">23752505</pub-id>
 </element-citation>
</ref>
